Figure 1 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer
Year: 2026
Type: other
Abstract: CONSORT diagram of enrolled, randomized, and treated patients in the study. MD, medical doctor; PD, progressive disease; SOC, standard of care. *Registration number was 78, one patient was registered twice.
Authors: Atish D. Choudhury, Caiwei Zhong, Wanling Xie, Bose S. Kochupurakkal, Peter I-Fan Wu, Irbaz Bin Riaz, Ruolin Liu, David D. Yang, Edmund Folefac, Daniel Lee, Mamta Parikh, David J. Einstein, Elizabeth R. Kessler, Tina Mayer, Rana R. McKay, Amanda Pace, Kent W. Mouw, Li Chen, Viktor A. Adalsteinsson, Eliezer M. Van Allen, Charles A. Kunos, Steven D. Gore, Biswajit Das, Alan D’Andrea, Mary-Ellen Taplin, Geoffrey I. Shapiro
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7213537008
Cites:
Cited by:
Related to: